Holen Sie sich die Stockscreener-App
3.94
5.60%
0.19
Schlusskurs vom Vortag:
$3.75
Offen:
$3.8
24-Stunden-Volumen:
193.12K
Relative Volume:
0.37
Marktkapitalisierung:
$134.67M
Einnahmen:
$160.43M
Nettoeinkommen (Verlust:
$-227.64M
KGV:
-0.0573
EPS:
-68.77
Netto-Cashflow:
$-170.79M
1W Leistung:
+22.60%
1M Leistung:
+1.02%
6M Leistung:
-23.55%
1J Leistung:
+16.47%
1-Tages-Spanne:
$3.80
$3.99
1-Wochen-Bereich:
$3.175
$3.99
52-Wochen-Spanne:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Firmenname
Agenus Inc
Sektor
Branche
Telefon
781-674-4410
Adresse
3 FORBES ROAD, LEXINGTON, MA
Vergleichen Sie AGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
3.96 | 127.53M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.17 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.41 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.40 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.73 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-28 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-04-22 | Eingeleitet | B. Riley FBR | Buy |
| 2016-10-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Bestätigt | Maxim Group | Buy |
| 2016-03-11 | Hochstufung | Maxim Group | Hold → Buy |
| 2015-12-16 | Eingeleitet | Jefferies | Buy |
| 2015-10-27 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-07-27 | Bestätigt | MLV & Co | Buy |
| 2015-06-11 | Eingeleitet | Oppenheimer | Outperform |
| 2015-01-12 | Bestätigt | Maxim Group | Buy |
| 2015-01-09 | Bestätigt | MLV & Co | Buy |
| 2015-01-09 | Bestätigt | Maxim Group | Buy |
| 2014-12-19 | Bestätigt | Maxim Group | Buy |
| 2014-05-08 | Bestätigt | Maxim Group | Buy |
| 2014-03-14 | Bestätigt | MLV & Co | Buy |
| 2013-10-08 | Bestätigt | Maxim Group | Buy |
| 2012-01-05 | Eingeleitet | William Blair | Outperform |
| 2011-12-01 | Eingeleitet | Global Hunter Securities | Buy |
Alle ansehen
Agenus Inc Aktie (AGEN) Neueste Nachrichten
What risks investors should watch in Agenus Inc. stockEarnings Overview Summary & Daily Stock Trend Reports - ulpravda.ru
Is Agenus Inc. stock attractive for income investorsNew Guidance & Low Risk Entry Point Guides - ulpravda.ru
Will Agenus Inc. stock sustain high P E ratiosJuly 2025 Setups & Community Verified Swing Trade Signals - ulpravda.ru
Agenus amends Ligand agreement, modifies warrant holder rights - TipRanks
How geopolitical tensions affect Agenus Inc. stockMarket Trend Review & Weekly Watchlist for Consistent Profits - ulpravda.ru
Agenus unit, MiNK surges after peer-reviewed data for lead drug - MSN
Is Agenus Inc. stock a good choice for value investorsEarnings Forecast Updates & Outstanding Growth Stocks - ulpravda.ru
What valuation multiples suggest for Agenus Inc. stockHead and Shoulders Patterns & Superior Portfolio Investment - ulpravda.ru
Why Agenus Inc. stock is a must watch in 2025Analyst Upgrades & Outstanding Capital Tips - ulpravda.ru
Aug Summary: Is Agenus Inc stock attractive for income investorsWeekly Risk Report & Stepwise Entry and Exit Trade Signals - moha.gov.vn
Agenus (AGEN) Q4 2024 Earnings Call Transcript - AOL.com
Agenus (AGEN) Q3 2024 Earnings Call Transcript - The Motley Fool
Is Agenus Inc a good long term investmentRSI Overbought/Oversold & Learn the Basics of Investing in 5 Days - earlytimes.in
H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN
Short Interest in Agenus Inc. (NASDAQ:AGEN) Rises By 56.5% - MarketBeat
Agenus publishes C-800-01 trial data in The Journal for Immunotherapy of Cancer - MSN
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC - BioSpace
Agenus reports positive results for cancer immunotherapy in ovarian cancer By Investing.com - Investing.com Nigeria
Agenus Inc AJ8 Stock Analysis and ForecastVolume Analysis Techniques & High Return Investment Ideas - earlytimes.in
Botensilimab + Balstilimab in Refractory MSS mCRC: Insights from an ESMO AnalysisAgenus - Oncodaily
Agenus publishes C-800-01 trial data in The Journal for ImmunoTherapy of Cancer - TipRanks
Agenus reports positive results for cancer immunotherapy in ovarian cancer - Investing.com India
Agenus BOT and BAL data faces comparison with standard care - Traders Union
How Agenus Inc. (AJ8) stock behaves under inflation pressureEarnings Risk Report & Stepwise Trade Signal Implementation - Улправда
Can Agenus Inc. stock attract ESG capital inflows2025 Trading Recap & Technical Analysis for Trade Confirmation - ulpravda.ru
Aug PreEarnings: How Agenus Inc. (AJ8) stock behaves under inflation pressureJuly 2025 Retail & Step-by-Step Trade Execution Guides - Улправда
Will Agenus Inc. (AJ8) stock benefit from Fed rate cutsEarnings Overview Summary & Low Risk High Win Rate Stock Picks - DonanımHaber
Options Flow: Will Agenus Inc. (AJ8) stock announce a stock split2025 Support & Resistance & Precise Swing Trade Alerts - Улправда
Can Agenus Inc. stock reach $100 price targetJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - Улправда
Will Agenus Inc. (AJ8) stock announce a stock splitJuly 2025 Snapshot & Fast Moving Trade Plans - Улправда
What catalysts could drive Agenus Inc. stock higher2025 Trade Ideas & Fast Entry Momentum Alerts - ulpravda.ru
AGEN (Agenus) EV-to-OCF : -1.74 (As of Dec. 18, 2025) - GuruFocus
Agenus Inc. (NASDAQ:AGEN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Agenus (NASDAQ: AGEN) pays CEO Garo Armen 4,316 fully vested shares - Stock Titan
How CTLA-4 Has Re-Emerged as a Central Driver of the Next Immuno-Oncology RevolutionAgenus - Oncodaily
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era - The Manila Times
BOT/BAL Shows Response in Undifferentiated Pleiomorphic Sarcoma – Agenus - Oncodaily
Is Agenus Inc. (AJ8) stock testing key supportEarnings Miss & Daily Technical Stock Forecast Reports - Newser
Will Agenus Inc. (AJ8) stock sustain bullish trend into 2025Trade Risk Report & Free High Return Stock Watch Alerts - Newser
Agenus accelerates global access with BATTMAN update - Traders Union
Why Agenus Inc. (AJ8) stock fits value portfoliosBull Run & Stock Timing and Entry Methods - Newser
Transcript : Agenus Inc.Shareholder/Analyst Call - MarketScreener
Will Agenus Inc. (AJ8) stock top growth indexesRate Cut & Verified Momentum Stock Ideas - Newser
Agenus (AGEN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Agenus Inc. stock rebound after recent weaknessJuly 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Here's Why Grail Soared, Again, in November - AOL.com
Finanzdaten der Agenus Inc-Aktie (AGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):